ADUS Addus HomeCare Corp
Services-Home Health Care Services · Nasdaq · SEC CIK 1468328 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY11.5%
TTM net income YoY29.7%
TTM EPS YoY29.0%
Revenue 3-yr CAGR13.4%
Net income 3-yr CAGR24.4%
Margins
Gross margin32.3%
Operating margin10.3%
Net margin7.4%
FCF margin9.6%
EBITDA margin11.4%
Returns
ROE10.0%
ROA7.7%
ROIC (approx.)10.5%
Asset turnover1.05x
Leverage & solvency
Liabilities / assets18.6%
Debt / equity0.02x
Current ratio1.64x
Interest coverage19.72x
Cash quality & payout
Operating cash flow / net income1.37x
Accruals ratio-2.9%
Payout ratio—
Capex / revenue0.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $387.73M | $377.42M | $363.61M | $373.08M | $362.30M | $349.44M | $337.71M | $297.14M |
| Cost of revenue | $263.33M | $255.86M | $247.74M | $249.47M | $245.59M | $235.57M | $230.03M | $195.66M |
| Gross profit | $124.40M | $121.56M | $115.87M | $123.61M | $116.72M | $113.88M | $107.68M | $101.48M |
| SG&A expense | $80.44M | $78.49M | $77.77M | $77.18M | $79.37M | $77.08M | $73.22M | $71.36M |
| Operating income | $39.82M | $38.94M | $34.07M | $42.28M | $32.94M | $32.89M | $30.51M | $26.91M |
| Interest expense | $1.26M | $1.72M | $2.15M | $2.73M | $3.34M | $3.52M | $4.02M | $2.29M |
| Pretax income | $39.14M | $37.78M | $32.43M | $40.15M | $30.35M | $29.95M | $27.00M | $26.21M |
| Income tax | $10.55M | $10.18M | $7.36M | $10.37M | $7.51M | $7.89M | $5.77M | $6.69M |
| Net income | $28.59M | $27.61M | $25.07M | $29.78M | $22.85M | $22.05M | $21.23M | $19.53M |
| EBITDA | $43.96M | $43.07M | $38.10M | $46.42M | $37.34M | $36.80M | $34.46M | $30.13M |
| EPS (basic) | 1.56 | 1.51 | 1.38 | — | 1.26 | 1.22 | 1.18 | — |
| EPS (diluted) | 1.54 | 1.49 | 1.36 | — | 1.24 | 1.20 | 1.16 | — |
| Weighted avg. shares (diluted) | 18.57M | 18.47M | 18.49M | — | 18.39M | 18.33M | 18.31M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $98.48M | $99.57M | $103.06M | $81.62M | $101.92M | $91.18M | $96.95M | $98.91M |
| Receivables | $160.87M | $145.12M | $144.82M | $151.69M | $134.05M | $140.10M | $134.61M | $122.88M |
| Current assets | $281.23M | $284.15M | $272.88M | $269.49M | $260.66M | $263.05M | $257.83M | $260.38M |
| PP&E, net | $23.73M | $23.85M | $24.66M | $25.00M | $24.44M | $24.44M | $24.70M | $24.70M |
| Goodwill | $1.01B | $1.01B | $996.68M | $996.70M | $988.55M | $969.82M | $972.35M | $970.56M |
| Intangibles | $97.47M | $99.40M | $100.49M | $102.41M | $104.40M | $105.66M | $107.64M | $109.64M |
| Total assets | $1.45B | $1.46B | $1.44B | $1.44B | $1.42B | $1.41B | $1.41B | $1.41B |
| Current liabilities | $171.44M | $168.15M | $149.47M | $149.49M | $156.80M | $151.38M | $147.94M | $155.87M |
| Long-term debt | $21.92M | $61.60M | $91.27M | $120.96M | $150.64M | $169.06M | $198.74M | $218.44M |
| Total debt | $21.92M | $61.60M | $91.27M | $120.96M | $150.64M | $169.06M | $198.74M | $218.44M |
| Total liabilities | $270.42M | $308.33M | $319.54M | $352.00M | $372.96M | $387.08M | $412.20M | $442.14M |
| Shareholders' equity | $1.18B | $1.15B | $1.12B | $1.09B | $1.05B | $1.02B | $995.38M | $970.49M |
| Net debt | -$76.56M | -$37.97M | -$11.79M | $39.34M | $48.72M | $77.88M | $101.79M | $119.53M |
| Shares outstanding | 18.63M | 18.67M | 18.66M | 18.52M | 18.48M | 18.41M | 18.40M | 18.15M |
| Cash flow statement | ||||||||
| Operating cash flow | $40.91M | $40.01M | $52.37M | $18.76M | $51.27M | $22.53M | $18.95M | $10.42M |
| Capital expenditure | $2.11M | $1.34M | $1.71M | $2.66M | $1.92M | $1.25M | $1.88M | $1.70M |
| Free cash flow | $38.81M | $38.67M | $50.65M | $16.10M | $49.35M | $21.28M | $17.07M | $8.72M |
| Investing cash flow | -$2.00M | -$13.51M | -$1.69M | -$10.06M | -$22.76M | $1.70M | -$1.38M | -$354.49M |
| Financing cash flow | -$40.01M | -$30.00M | -$29.23M | -$29.01M | -$17.76M | -$30.00M | -$19.53M | $220.13M |
| Depreciation & amortization | $4.14M | $4.12M | $4.03M | $4.15M | $4.41M | $3.91M | $3.94M | $3.21M |
| Stock-based compensation | $3.01M | $4.39M | $5.00M | $4.55M | $4.29M | $4.42M | $3.17M | $2.86M |
Free plan shows the latest 8 periods; Pro shows all 67 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.